Cargando...
Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature
Gefitinib is a selective epidermal growth factor receptor tyrosine kinase inhibitor utilized for the treatment of advanced non-small cell lung carcinoma. The most commonly reported adverse event during gefitinib therapy is skin rash, particularly a papulopustular acne-like eruption. Cutaneous toxici...
Guardado en:
| Publicado en: | Exp Ther Med |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
D.A. Spandidos
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4726852/ https://ncbi.nlm.nih.gov/pubmed/26889239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2015.2881 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|